PYRROLO SULFONAMIDE COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (ROR-GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
申请人:Steeneck Christoph
公开号:US20140142082A1
公开(公告)日:2014-05-22
The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administrating these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolo sulfonamide compounds of Formula (1) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof.
该发明提供了调节孤儿核受体RORy的调节剂,并通过向需要治疗RORy介导疾病的人类或哺乳动物施用这些新型RORy调节剂的方法进行治疗。具体而言,本发明提供了化合物1的吡咯磺酰胺化合物及其对映体,异构体,互变异构体,溶剂化物和药学上可接受的盐。